New Compounds for Making Chiral Drugs and Molecules

Summary of the technology

This invention introduces atropisomeric 1,8-bisphenol naphthalenes and their derivatives, which are designed for enantioselective recognition and asymmetric synthesis. Chiral drugs, which are compounds that exist in two mirror-image forms (enantiomers), account for over half of all medications currently in use. These enantiomers can exhibit significantly different biological activities, making the ability to separate and utilize the active form crucial for effective treatment. The new compounds developed through this invention can resolve enantiomers and facilitate the synthesis of chiral drugs, enhancing their effectiveness and safety. For example, these compounds can be applied in the development of chiral catalysts or sensors, improving the efficiency of chemical reactions that require specific stereochemistry.

Georgetown University

Details of the Technology Offer

BACKGROUND
The field of asymmetric synthesis is crucial for producing chiral compounds used in pharmaceuticals and other applications. Traditional methods often struggle with the resolution of enantiomers due to rapid racemization. This invention addresses these challenges by providing stable 1,8-bisphenol naphthalene derivatives that can be isolated and utilized in various chemical processes, including drug discovery and molecular recognition.

Benefit

  • Enables efficient resolution of enantiomers for pharmaceutical applications.
  • Offers a stable platform for asymmetric synthesis, reducing waste and improving yields.
  • Facilitates the design of advanced molecular devices with unique properties.
  • Enhances the ability to create chiral compounds critical for various industries.

Market Application

  • Potential use in pharmaceutical development for producing enantiomerically pure drugs.
  • Possible application in materials science for creating chiral materials with specific properties.
  • Can be implemented in research laboratories focusing on asymmetric catalysis and molecular recognition.
  • Suitable for industries involved in drug discovery and development of chiral sensors.

Intellectual property status

Granted Patent

Patent number : Patent No. 9,085,511

Where : USA

Related Keywords

  • Medical Research
  • Medical/health
  • Medical equipment
  • asymmetric synthesis
  • atropisomeric compounds
  • chiral catalysis
  • enantioselective recognition
  • molecular devices

About Georgetown University

Our mission is to advance GU’s innovations through strategic alliances and new venture creation, to facilitate the translation of research breakthroughs into tangible solutions, and to cultivate a dynamic and inclusive environment for entrepreneurship. We advance this mission in support of the GU community and for the benefit of society.

Georgetown University

Never miss an update from Georgetown University

Create your free account to connect with Georgetown University and thousands of other innovative organizations and professionals worldwide

Georgetown University

Send a request for information
to Georgetown University

About Technology Offers

Technology Offers on Innoget are directly posted
and managed by its members as well as evaluation of requests for information. Innoget is the trusted open innovation and science network aimed at directly connect industry needs with professionals online.

Help

Need help requesting additional information or have questions regarding this Technology Offer?
Contact Innoget support